Publisher
Springer Berlin Heidelberg
Reference56 articles.
1. Ahmann FR, Pugh R (1987) Short-term chemotherapy of poor-prognosis metastatic breast cancer with three non-cross resistant chemotherapy regimens. A Southwest Oncology Group study. Cancer 59: 239–244
2. Aisner J, Weinberg V, Perloff M, Weiss R, Perry M, Korzun A, Ginsberg S, Holland JF (1987) Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each±MER) for metastatic carcinoma of the breast: a CALGB study. J Clin Oncol 5: 1523–1533
3. Allegra JC, Woodcock T, Woolf S, Henderson IC, Bryan S, Reisman A, Dukart G (1985) A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer. Invest New Drugs 3: 153–161
4. Armand JP, Hurteloup P, Hayat M, Chauvergne J, Fargeot P, Schraub S (1984) Phase III chemotherapy comparing FAC vs FEC in advanced breast cancer: preliminary results. Proc Am Soc Clin Oncol 3: 118
5. Baretta G, Locatelli C, Tabiadon D, Labianca R, Fraschini P, Luporini G (1987) Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen. Oncology 44: 6–12